Filter
1848
Filtered Results: 1848
Text search:
pharmaceutical
guidelines
Featured
Recommendations
178
New Publications
499
Language
Document type
No document type
972
Studies & Reports
315
Guidelines
310
Strategic & Response Plan
86
Manuals
85
Fact sheets
26
Training Material
24
Situation Updates
14
Resource Platforms
8
Infographics
4
Brochures
3
Online Courses
1
Countries / Regions
Kenya
78
India
77
Ethiopia
71
Global
54
South Africa
50
Nigeria
42
Western and Central Europe
41
Uganda
39
Sierra Leone
38
Liberia
36
Ghana
29
Namibia
29
Zambia
28
Rwanda
27
Tanzania
27
Nepal
26
Malawi
26
Africa
24
Ukraine
19
Philippines
19
Latin America and the Carribbean
19
Bangladesh
19
Zimbabwe
18
Eastern Europe
17
Lesotho
16
Cambodia
16
Indonesia
12
Botswana
11
Myanmar / Burma
11
Eswatini/ Swaziland
11
Syria
9
Germany
9
Congo, Democratic Republic of
9
South–East Asia Region
9
Eastern Europe and Central Asia
9
Asia
8
West and Central Africa
8
East and Southern Africa
8
Brazil
8
Russia
8
Senegal
7
Cameroon
6
Guinea
6
Thailand
5
Middle East and North Africa
5
South Sudan
5
Benin
4
Chile
4
Albania
4
Burkina Faso
4
Mozambique
4
Haiti
4
Western Pacific Region
4
Laos
3
USA
3
United Kingdom
3
Vietnam
3
Papua New Guinea
3
Sudan
3
Mali
3
Pakistan
3
Tajikistan
2
China
2
Fiji
2
Kyrgyzstan
2
Jordan
2
North America
2
Yemen
2
Iraq
2
North Macedonia
1
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Afghanistan
1
Peru
1
Malaysia
1
Bulgaria
1
Armenia
1
Venezuela
1
Lithuania
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Portugal
1
Spain
1
Southern Africa
1
Bolivia
1
Argentina
1
Lebanon
1
Moldova
1
Egypt
1
Romania
1
Palestine
1
Georgia
1
Central African Republic
1
Angola
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
795
Clinical Guidelines
137
Public Health
100
Key Resources
70
Women & Child Health
52
Pharmacy & Technologies
35
Capacity Building
14
Annual Report MEDBOX
2
Toolboxes
AMR
188
Pharmacy
177
COVID-19
136
TB
101
HIV
100
Mental Health
92
Rapid Response
57
NCDs
44
Caregiver
40
Planetary Health
40
NTDs
36
Ebola
28
Conflict
24
Global Health Education
20
Health Financing Toolbox
12
Disability
11
Polio
11
Specific Hazards
10
Refugee
7
Natural Hazards
7
Cholera
3
Social Ethics
3
Zika
3
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
Ethiopia has been repeatedly affected by conflict, flooding, drought, and disease outbreaks in the past years. As of January 2024, the country is actively responding to the longest recorded cholera outbreak which started in August 2022, recurrent measles outbreaks which started in August 2021, and t...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
This is an update (third edition) of the BACPR Standards & Core Components and represents current evidence-based best practice and a pragmatic overview of the structure and function of Cardiovascular Prevention and Rehabilitation Programmes (CPRPs) in the UK. The previously described seven standards...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such as heart disease, cancer, diabetes, and chronic respiratory diseases, following the commitments made at high-level United Nations meetings. It highlights ...
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NCDs) into existing health programs for HIV/AIDS, tub...
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over...
The Global Asthma Report (GAR) 2022, prepared by the Global Asthma Network (GAN), is the fourth such report (others 2011, 2014, 2018). GAN builds upon the work of the International Study of Asthma and Allergies in Childhood (ISAAC) and The International Union Against Tuberculosis and Lung Disease (T...
This integrated operational framework provides an overview of the connections between mental health, neurological and substance use (MNS) conditions, and their links to health, well-being and the broader public health and sustainable development agenda. The need for integrated approaches is increasi...
Cureus. 2015 Nov; 7(11): e372.
Published online 2015 Nov 3. doi: 10.7759/cureus.372
PMCID: PMC4671837
PMID: 26677422
